Market Access
Access market access solutions designed to anticipate payer shifts, interpret policy impact and make confident market access decisions faster.
Driving confident Market Access strategy and decisions in a changing landscape
Clarivate delivers a comprehensive market access intelligence and strategy suite designed to cut through complexity. By combining AI powered, pharmacist validated insights with analytics, consulting expertise, and targeted learning, we help teams anticipate payer policy change, understand access implications, and act with confidence across the lifecycle.
Confidence in Market Access starts here
Trusted market access intelligence, real‑world insight, and expert guidance for life sciences.
Unmatched domain expertise
Tap into market access data curated by pharmacists, analysts, and access specialists to turn complex policy and coverage data into clear actions for life sciences.
Clear payer and policy signals
Gain clear visibility into coverage, policy, and restriction changes—so teams can identify risk, interpret implications, and respond with confidence.
Evidence‑driven access strategy
Strengthen market access decisions with real‑world insights and expert interpretation that help teams anticipate payer shifts, build defensible assumptions, and optimize access across the lifecycle.
Consistent capability and behavior change
Build consistent market access fluency across field, MA, FRM, and commercial teams with KOL‑designed, multi‑modal learning that improves execution and strengthens payer engagement.
Trusted, Market Access solutions backed by deep expertise
From launch to pull through, access trusted market access solutions and expertise to reduce uncertainty and improve patient access.
DRG Fingertip Foundations
Access the industry’s most accurate pharmacist‑validated market access intelligence—coverage, restrictions, source transparency, and real‑time policy change tracking.
Included products:
- Fingertip Coverage
- Fingertip Restrictions
- Fingertip Publisher
- Fingertip PolicyTrack
DRG Fingertip Insights
Navigate payer, PBM, and provider dynamics with expert‑authored insights across national, state, and metro markets to strengthen targeting and pull‑through.
Included products:
- Enrolled Lives: Quantify market opportunity and monitor shifts across payers, employers, and PBMs
- Employer Vantage, Managed Market Surveyor, Pharmacy Benefit Evaluator/PBM Profiles
- Payer Insights: Understand payer decision-makers and contracting power.
- National MCO Analyzer, Health Plan Analysis, Market Overviews
- Provider Insights: Pinpoint high-impact provider organizations for pull-through and field activities.
- IDN Profiles, Power Profiles, Market Overviews (shared across payer and provider insights)
DRG Fusion
Fuses real-world access, patient, and provider signals to expose performance drivers and enable faster, high-impact insight to action decisions.
Market Access Consulting
Access end‑to‑end strategic support—from evidence strategy and U.S. market entry to payer engagement, scenario planning, and launch readiness—backed by deep market access expertise.
Market Access Learning
KOL‑designed, market‑access‑specific learning programs that build cross‑functional fluency across sales, MA, FRMs, and medical to improve consistent, confident execution.
Included components:
- Multi-modal eLearning and workshops
- Scenario-based application
- Coaching guides and role-based curriculum
Questions we help answer
Strategic market access questions teams face across planning, launch, and execution.
- How do we remove access barriers and accelerate patient starts?
- How do we anticipate market shifts and act decisively?
- How can we confidently navigate U.S. market access requirements and prioritize the right accounts for entry?
- How do we uncover why performance varies across plans, providers, and geographies?
- How do we build consistent, cross‑functional market access capability across our teams?
Get expert market access data and guidance
Talk to us about your market access challenges.
Why Clarivate market access solutions
20+
15+ years
2.5m+
30+ years
Frequently asked questions
Market access refers to the strategies, evidence, and engagement required to secure payer coverage, minimize restrictions, and ensure patients can access therapies. Effective market access relies on timely policy intelligence, payer insight, and expert interpretation to support confident decisions across the product lifecycle.
Clarivate brings together AI‑powered, pharmacist‑validated policy intelligence and real‑world insights to help teams detect emerging restrictions early, understand their implications, and respond proactively. With visibility into coverage shifts, utilization management updates, and benefit design changes, your teams can act before access barriers impact pull‑through.
Clarivate delivers market access intelligence that is clinically validated, deeply contextualized, and built specifically for how payer decisions are made. Our pharmacist‑reviewed policy criteria, detailed coverage insights, and expert‑authored market context go far beyond standard datasets or surface‑level tools—helping teams interpret complex access requirements with confidence.
Clarivate market access experts interpret complex benefit designs, payer rules, utilization management criteria, and local market dynamics. Their guidance helps teams align assumptions, reduce uncertainty in forecasts, pressure‑test payer strategies, and make faster, more confident decisions rooted in clinical and real‑world context.
Clarivate’s Commercial Consulting team provides strategic support across the entire access lifecycle—from evidence planning and payer landscape assessment to launch readiness, scenario modeling, and cross‑functional alignment. We help teams interpret insights, strengthen assumptions, and build strategies that reduce uncertainty and improve access outcomes.
Fingertip Foundations provides the essential market access intelligence needed to understand coverage, restrictions, payer policies, and policy changes. It answers questions like “What is a payer covering? What restrictions exist? What changed?” by delivering pharmacist-validated data, transparent source documentation, and policy tracking.
Fingertip Insights builds on that foundation by helping teams understand the broader market dynamics behind access decisions. Through expert-authored analysis of payers, PBMs, employers, and provider organizations, it helps answer questions like “Where is the market opportunity? Which accounts should we prioritize? Who influences access decisions?” to support smarter targeting, pull-through, and strategic planning.
Clarivate delivers market‑access‑specific learning designed by KOLs, subject‑matter experts, and instructional designers. Through multi‑modal training—including eLearning, workshops, simulations, and coaching tools—we help sales, MA, FRMs, medical, and commercial teams build consistent fluency, strengthen execution, and confidently navigate payer and provider dynamics.
Explore our Market Access solutions
Bring treatments to patients faster.
Resources
The market access “sweet spots” where payers reimburse more convenient therapies
U.S. payers often say they “don’t pay for convenience,” yet across several therapeutic areas, long-acting injectables (LAIs) command premium prices and broad coverage. In areas like HIV prevention and opioid…
How the Inflation Reduction Act could impact access to more convenient therapeutics
Many biologic drugs start their journey as intravenous (IV) therapies, administered in a clinic or infusion center. Later, some launch as self-administered subcutaneous (SC) injections. For patients, the appeal is…
This small biotech notched a big win for rare disease patients with a canny market access strategy
Immunoglobin A nephropathy (IgAN), also known as Berger’s disease, is a rare autoimmune disease of the kidneys that can, over 10 to 20 years, progress to end-stage renal disease. Clarivate…
PBM GPO market share shifts as health plan enrollment continues to churn
Market share of pharmacy benefit manager-led group purchasing organization (PBM GPO) covered lives increased for Zinc Health Services, declined for Ascent Health Services and remained nearly flat for Emisar Pharma…